BioAssets Development

United States
Massachusetts, United States, Wellesley
+1 339-686-2000 ★

Company profile

BioAssets Development company profile

BioAssets Development Corporation, a biopharmaceutical company, develops spine indications for biologic drugs. It focuses on the development of a tumor necrosis factor alpha (TNF) inhibitor therapy to treat the underlying cause of pain in sciatica. It markets tumor necrosis factor alpha (TNF) inhibitors, which include monoclonal antibodies, infliximab or adalimumab, TNF-receptor fusion protein etanercept, and biologic drugs for the treatment of inflammatory diseases, such as rheumatoid arthritis, Crohn's disease, and psoriasis. The company’s lead program also tests the potential of TNF inhibitors to treat pain and prevent nerve damage in patients with spinal disorders by treating the neuro-inflammatory disease mechanism...... For more information, log in to dureach.com to view the full company profile.

Business identity

Phone number
+1 339-686-2000
Operating status
Closed
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$0+
Founded
2005-01-01

Headquarters

Headquarters
Massachusetts, United States, Wellesley
Postal code
02482
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
1
Total equity funding
$3.9M
Last funding
Series Unknown / $3.9M / 2009-09-04
Last equity funding
Series Unknown / $3.9M
Founders
2
Articles
1
Closed on
2012-06-18
Exited on
2009-10-26

Founders and investors

Founders

James R. GormanRobert Kamen

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.